Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
Crossref DOI link: https://doi.org/10.1007/s00228-017-2254-y
Published Online: 2017-04-08
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kheloufi, F
Default, A
Rouby, F
Laugier-Castellan, D
Boyer, M
Rodrigues, B
Ponte-Astoul, J
Jean-Pastor, MJ
Blin, O
Micallef, J
License valid from 2017-04-08